Frontiers in Cardiovascular Medicine
MAY 19, 2024
Prior transapical transcatheter aortic valve replacement (TA-TAVR) may complicate the procedure and is therefore considered a relative contraindication. He had already undergone cardiac surgery in the form of coronary artery bypass grafting at the age of 64 and TA-TAVR at 79 years.
Open Heart
APRIL 27, 2023
Background and aims Randomised controlled trials comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) were performed in highly selected populations and data regarding long-term secondary complications beyond mortality are scarce. Results The study included 9355 SAVR and 2641 TAVR patients.
DAIC
FEBRUARY 29, 2024
ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24 24 and how those may impact clinical practice and patient care in this deep dive clinical trial session.
Cardiology Update
APRIL 9, 2024
SMART 4 ( NCT04722250 ) studied patients with severe aortic stenosis and a small aortic annulus who underwent transcatheter aortic valve replacement (TAVR). A total of 716 patients underwent TAVR with either a self-expanding supraannular valve or a balloon-expandable valve. of patients in the PCI group compared to 3.4%
DAIC
MARCH 25, 2024
SHASTA-2—looks at a new medicine plozasiran on the treatment of hypertriglyceridemia SMART Trial—a head-to-head trial of the self-expanding vs. a balloon-expanding TAVR DanGer Shock—brings equipoise to how cardiogenic shock is treated in general, looking at the use of a transvalvular mico-axial flow pump in patients who have infarct or heart attack (..)
Expert insights. Personalized for you.
52 
Let's personalize your content